Summary of 80 candidate gene single-nucleotide polymorphisms
Gene . | SNP ID . | Gene description . | Chromosome . | Minor allele frequency . | Minor allele . |
---|---|---|---|---|---|
Apoptosis pathway (n = 30) | |||||
BCL2 | rs1801018 | B-cell CLL/lymphoma 2 | 18 | 0.414 | G |
BCL2 | rs2279115 | B-cell CLL/lymphoma 2 | 18 | 0.486 | C |
BAX | rs11667351 | BCL2-associated X protein | 19 | 0.129 | G |
BCL2L2 | rs7042474 | BCL2-like 2 | 9 | 0.127 | T |
BCL6 | rs1056932 | B-cell CLL/lymphoma 6 | 3 | 0.341 | C |
BCL6 | rs11545363 | B-cell CLL/lymphoma 6 | 3 | 0 | C |
BCL2L11 | rs6746608 | BCL2-like 11 | 2 | 0.450 | A |
BCL2L11 | rs12613243 | BCL2-like 11 | 2 | 0.072 | C |
BIRC5 | rs9904341 | Survivin | 17 | 0.328 | C |
BIRC5 | rs2071214 | Survivin | 17 | 0.057 | G |
CASP1 | rs580253 | Caspase 1 | 11 | 0.184 | T |
CASP3 | rs1049253 | Caspase 3 | 4 | 0.167 | C |
CASP7 | rs7922608 | Caspase 7 | 10 | 0.313 | G |
CASP8 | rs1045485 | Caspase 8 | 2 | 0.126 | C |
CASP8 | rs3769818 | Caspase 8 | 2 | 0.276 | T |
CASP8 | rs3834129 | Caspase 8 | 2 | 0.461 | C |
CASP9 | rs4645981 | Caspase 9 | 1 | 0 | C |
CASP10 | rs13010627 | Caspase 10 | 2 | 0.074 | A |
CASP10 | rs13006529 | Caspase 10 | 2 | 0.458 | A |
FASL | rs763110 | Fas ligand (TNF superfamily 6) | 1 | 0.383 | T |
FAS | rs2234767 | Fas (TNF receptor superfamily 6) | 10 | 0.114 | A |
FAS | rs1800682 | Fas (TNF receptor superfamily 6) | 10 | 0.473 | C |
FAS | rs3218619 | Fas (TNF receptor superfamily 6) | 10 | 0.003 | A |
FAS | rs3218612 | Fas (TNF receptor superfamily 6) | 10 | 0.042 | G |
FAS | rs2234978 | Fas (TNF receptor superfamily 6) | 10 | 0.331 | T |
APAF1 | rs1439123 | Apoptotic peptidase activating factor 1 | 12 | 0.224 | C |
APAF1 | rs2288713 | Apoptotic peptidase activating factor 1 | 12 | 0.103 | G |
TNFR2 | rs1061622 | TNF receptor superfamily, member 1B | 1 | 0.22 | G |
PDCD1 | rs2227981 | Programmed cell death 1 | 2 | 0.418 | T |
GZMB | rs7144366 | Granzyme B | 14 | 0.391 | T |
Angiogenesis (n = 7) | |||||
VEGFA | rs699947 | VEGFA | 6 | 0.476 | A |
VEGFA | rs833061 | VEGFA | 6 | 0.480 | C |
VEGFA | rs2010963 | VEGFA | 6 | 0.335 | C |
VEGFA | rs3025039 | VEGFA | 6 | 0.142 | T |
VEGFR2 | rs1531289 | VEGF receptor 2 | 4 | 0.302 | A |
VEGFR2 | rs1870377 | VEGF receptor 2 | 4 | 0.228 | A |
VEGFR2 | rs2305948 | VEGF receptor 2 | 4 | 0.092 | T |
Myeloid growth (n = 14) | |||||
FLT3 | rs35602083 | fms-related tyrosine kinase 3 | 13 | 0.035 | T |
CSF3 | rs25645 | G-CSF | 17 | 0.389 | A |
CSF3 | rs1042658 | G-CSF | 17 | 0.337 | T |
CSF2 | rs25882 | GM-CSF | 5 | 0.225 | C |
JAK3 | rs3008 | Janus kinase 3 | 19 | 0.447 | C |
JAK3 | rs3212713 | Janus kinase 3 | 19 | 0.341 | A |
IL1A | rs17561 | Interleukin 1 α | 2 | 0.274 | T |
IL1A | rs1800587 | Interleukin 1 α | 2 | 0.277 | T |
IL1B | rs1143634 | Interleukin 1 β | 2 | 0.222 | T |
IL1B | rs1143633 | Interleukin 1 β | 2 | 0.358 | A |
IL1B | rs1143627 | Interleukin 1 β | 2 | 0.371 | C |
IL1B | rs16944 | Interleukin 1 β | 2 | 0.371 | A |
IL1R | rs2228139 | Interleukin 1 receptor, type I | 2 | 0.060 | G |
IL1R | rs315952 | Interleukin 1 receptor antagonist | 2 | 0.282 | C |
WT1 signaling (n = 7) | |||||
WT1 | rs1799937 | Wilms tumor 1 | 11 | 0.244 | C |
WT1 | rs2234591 | Wilms tumor 1 | 11 | 0.006 | G |
WT1 | rs2234590 | Wilms tumor 1 | 11 | 0.003 | G |
WT1 | rs2301254 | Wilms tumor 1 | 11 | 0.380 | C |
WT1 | rs2301252 | Wilms tumor 1 | 11 | 0.380 | T |
WT1 | rs2301250 | Wilms tumor 1 | 11 | 0.380 | T |
WT1 | rs6508 | Wilms tumor 1 | 11 | 0.067 | A |
Xenobiotic metabolism (n = 13) | |||||
ABCB1 | rs1045642 | Multidrug resistance 1 | 7 | 0.474 | C |
ABCB1 | rs2032582 | Multidrug resistance 1 | 7 | 0.466 | T/G/A |
ABCB1 | rs1128503 | Multidrug resistance 1 | 7 | 0.440 | T |
ABCG2 | rs2231142 | Breast cancer resistance protein | 4 | 0.102 | A |
ABCG2 | rs2231137 | Breast cancer resistance protein | 4 | 0.057 | A |
CYP3A5 | rs776746 | Cytochrome P450, family 3, A5 | 7 | 0.060 | A |
CYP3A5 | rs28383469 | Cytochrome P450, family 3, A5 | 7 | 0 | G |
CYP3A5 | rs28383468 | Cytochrome P450, family 3, A5 | 7 | 0.006 | T |
HOCT1 | rs1867351 | Solute carrier family 22, member 1 | 6 | 0.227 | G |
HOCT1 | rs12208357 | Solute carrier family 22, member 1 | 6 | 0.070 | T |
HOCT1 | rs683369 | Solute carrier family 22, member 1 | 6 | 0.201 | G |
HOCT1 | rs2282143 | Solute carrier family 22, member 1 | 6 | 0.019 | T |
HOCT1 | rs628031 | Solute carrier family 22, member 1 | 6 | 0.374 | A |
Interferon signaling (n = 4) | |||||
IFNG | rs1861494 | Interferon γ | 12 | 0.274 | C |
IFNG | rs2069705 | Interferon γ | 12 | 0.326 | C |
IFNGR1 | rs3799488 | Interferon γ receptor 1 | 6 | 0.105 | C |
IFNGR2 | rs9808753 | Interferon γ receptor 2 | 21 | 0.164 | G |
Other (n = 5) | |||||
GNB3 | rs5443 | G protein β polypeptide 3 | 12 | 0.338 | T |
ULK3 | rs2290573 | Unc-51–like kinase 3 | 15 | 0.449 | T |
ORM | rs1126724 | Orosomucoid 1 | 9 | 0 | G |
ORM | rs3182041 | Orosomucoid 1 | 9 | 0.003 | G |
PTK2 | rs4554515 | PTK2 protein tyrosine kinase 2 | 8 | 0.452 | G |
Gene . | SNP ID . | Gene description . | Chromosome . | Minor allele frequency . | Minor allele . |
---|---|---|---|---|---|
Apoptosis pathway (n = 30) | |||||
BCL2 | rs1801018 | B-cell CLL/lymphoma 2 | 18 | 0.414 | G |
BCL2 | rs2279115 | B-cell CLL/lymphoma 2 | 18 | 0.486 | C |
BAX | rs11667351 | BCL2-associated X protein | 19 | 0.129 | G |
BCL2L2 | rs7042474 | BCL2-like 2 | 9 | 0.127 | T |
BCL6 | rs1056932 | B-cell CLL/lymphoma 6 | 3 | 0.341 | C |
BCL6 | rs11545363 | B-cell CLL/lymphoma 6 | 3 | 0 | C |
BCL2L11 | rs6746608 | BCL2-like 11 | 2 | 0.450 | A |
BCL2L11 | rs12613243 | BCL2-like 11 | 2 | 0.072 | C |
BIRC5 | rs9904341 | Survivin | 17 | 0.328 | C |
BIRC5 | rs2071214 | Survivin | 17 | 0.057 | G |
CASP1 | rs580253 | Caspase 1 | 11 | 0.184 | T |
CASP3 | rs1049253 | Caspase 3 | 4 | 0.167 | C |
CASP7 | rs7922608 | Caspase 7 | 10 | 0.313 | G |
CASP8 | rs1045485 | Caspase 8 | 2 | 0.126 | C |
CASP8 | rs3769818 | Caspase 8 | 2 | 0.276 | T |
CASP8 | rs3834129 | Caspase 8 | 2 | 0.461 | C |
CASP9 | rs4645981 | Caspase 9 | 1 | 0 | C |
CASP10 | rs13010627 | Caspase 10 | 2 | 0.074 | A |
CASP10 | rs13006529 | Caspase 10 | 2 | 0.458 | A |
FASL | rs763110 | Fas ligand (TNF superfamily 6) | 1 | 0.383 | T |
FAS | rs2234767 | Fas (TNF receptor superfamily 6) | 10 | 0.114 | A |
FAS | rs1800682 | Fas (TNF receptor superfamily 6) | 10 | 0.473 | C |
FAS | rs3218619 | Fas (TNF receptor superfamily 6) | 10 | 0.003 | A |
FAS | rs3218612 | Fas (TNF receptor superfamily 6) | 10 | 0.042 | G |
FAS | rs2234978 | Fas (TNF receptor superfamily 6) | 10 | 0.331 | T |
APAF1 | rs1439123 | Apoptotic peptidase activating factor 1 | 12 | 0.224 | C |
APAF1 | rs2288713 | Apoptotic peptidase activating factor 1 | 12 | 0.103 | G |
TNFR2 | rs1061622 | TNF receptor superfamily, member 1B | 1 | 0.22 | G |
PDCD1 | rs2227981 | Programmed cell death 1 | 2 | 0.418 | T |
GZMB | rs7144366 | Granzyme B | 14 | 0.391 | T |
Angiogenesis (n = 7) | |||||
VEGFA | rs699947 | VEGFA | 6 | 0.476 | A |
VEGFA | rs833061 | VEGFA | 6 | 0.480 | C |
VEGFA | rs2010963 | VEGFA | 6 | 0.335 | C |
VEGFA | rs3025039 | VEGFA | 6 | 0.142 | T |
VEGFR2 | rs1531289 | VEGF receptor 2 | 4 | 0.302 | A |
VEGFR2 | rs1870377 | VEGF receptor 2 | 4 | 0.228 | A |
VEGFR2 | rs2305948 | VEGF receptor 2 | 4 | 0.092 | T |
Myeloid growth (n = 14) | |||||
FLT3 | rs35602083 | fms-related tyrosine kinase 3 | 13 | 0.035 | T |
CSF3 | rs25645 | G-CSF | 17 | 0.389 | A |
CSF3 | rs1042658 | G-CSF | 17 | 0.337 | T |
CSF2 | rs25882 | GM-CSF | 5 | 0.225 | C |
JAK3 | rs3008 | Janus kinase 3 | 19 | 0.447 | C |
JAK3 | rs3212713 | Janus kinase 3 | 19 | 0.341 | A |
IL1A | rs17561 | Interleukin 1 α | 2 | 0.274 | T |
IL1A | rs1800587 | Interleukin 1 α | 2 | 0.277 | T |
IL1B | rs1143634 | Interleukin 1 β | 2 | 0.222 | T |
IL1B | rs1143633 | Interleukin 1 β | 2 | 0.358 | A |
IL1B | rs1143627 | Interleukin 1 β | 2 | 0.371 | C |
IL1B | rs16944 | Interleukin 1 β | 2 | 0.371 | A |
IL1R | rs2228139 | Interleukin 1 receptor, type I | 2 | 0.060 | G |
IL1R | rs315952 | Interleukin 1 receptor antagonist | 2 | 0.282 | C |
WT1 signaling (n = 7) | |||||
WT1 | rs1799937 | Wilms tumor 1 | 11 | 0.244 | C |
WT1 | rs2234591 | Wilms tumor 1 | 11 | 0.006 | G |
WT1 | rs2234590 | Wilms tumor 1 | 11 | 0.003 | G |
WT1 | rs2301254 | Wilms tumor 1 | 11 | 0.380 | C |
WT1 | rs2301252 | Wilms tumor 1 | 11 | 0.380 | T |
WT1 | rs2301250 | Wilms tumor 1 | 11 | 0.380 | T |
WT1 | rs6508 | Wilms tumor 1 | 11 | 0.067 | A |
Xenobiotic metabolism (n = 13) | |||||
ABCB1 | rs1045642 | Multidrug resistance 1 | 7 | 0.474 | C |
ABCB1 | rs2032582 | Multidrug resistance 1 | 7 | 0.466 | T/G/A |
ABCB1 | rs1128503 | Multidrug resistance 1 | 7 | 0.440 | T |
ABCG2 | rs2231142 | Breast cancer resistance protein | 4 | 0.102 | A |
ABCG2 | rs2231137 | Breast cancer resistance protein | 4 | 0.057 | A |
CYP3A5 | rs776746 | Cytochrome P450, family 3, A5 | 7 | 0.060 | A |
CYP3A5 | rs28383469 | Cytochrome P450, family 3, A5 | 7 | 0 | G |
CYP3A5 | rs28383468 | Cytochrome P450, family 3, A5 | 7 | 0.006 | T |
HOCT1 | rs1867351 | Solute carrier family 22, member 1 | 6 | 0.227 | G |
HOCT1 | rs12208357 | Solute carrier family 22, member 1 | 6 | 0.070 | T |
HOCT1 | rs683369 | Solute carrier family 22, member 1 | 6 | 0.201 | G |
HOCT1 | rs2282143 | Solute carrier family 22, member 1 | 6 | 0.019 | T |
HOCT1 | rs628031 | Solute carrier family 22, member 1 | 6 | 0.374 | A |
Interferon signaling (n = 4) | |||||
IFNG | rs1861494 | Interferon γ | 12 | 0.274 | C |
IFNG | rs2069705 | Interferon γ | 12 | 0.326 | C |
IFNGR1 | rs3799488 | Interferon γ receptor 1 | 6 | 0.105 | C |
IFNGR2 | rs9808753 | Interferon γ receptor 2 | 21 | 0.164 | G |
Other (n = 5) | |||||
GNB3 | rs5443 | G protein β polypeptide 3 | 12 | 0.338 | T |
ULK3 | rs2290573 | Unc-51–like kinase 3 | 15 | 0.449 | T |
ORM | rs1126724 | Orosomucoid 1 | 9 | 0 | G |
ORM | rs3182041 | Orosomucoid 1 | 9 | 0.003 | G |
PTK2 | rs4554515 | PTK2 protein tyrosine kinase 2 | 8 | 0.452 | G |